Asia share markets weaken as Moderna CEO warns on Omicron



By Scott Murdoch

HONG KONG, Nov 30 (Reuters) - Asian share markets weakened sharply in late trading Tuesday, giving up earlier gains as investors worried the Omicron variant will prove more resistant to vaccines and could cause more widespread global economic disruption.

The region's trading followed a brighter lead from Wall Street on Monday which reacted positively to news from U.S President Joe Biden that new lockdowns Link as a result of the variant were off the table for now.

Positive sentiment though was replaced swiftly with a sudden burst of risk aversion in most major asset markets across Asia after the head of drugmaker Moderna MRNA.O told the Financial Times Link that COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been against the Delta variant.

"It's not good news, and it's coming from someone who should know," said Commonwealth Bank of Australia currency strategist Joe Capurso. "Markets have reacted in exactly the way you'd expect them to with Aussie and kiwi taking the brunt."

Both the Australian AUD= and New Zealand dollars NZD= tumbled, with the Australian dollar at $0.7112, near it lowest in a year.

MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS was 0.45% lower later on Tuesday after initially being up as much as 0.52%.

"In the near term, there is a lot of uncertainty and the markets are starting to price in some level of risk," said Jack Siu, Credit Suisse's chief investment officer for Greater China.

"Essentially the recovery should stay underway but we are in an environment of volatility."

In Australia, the S&P/ASX200 .AXJO closed up 0.22% after earlier being up 1.15%.

Japan's Nikkei .N225 retraced all of its 1.2% gains notched earlier in the session and turned negative later on Tuesday.

Hong Kong's Hang Seng Index .HSI shed 1.86% while China's blue chip CSI 300 index .CSI300 was off 0.3%.

Selling in Hong Kong was exacerbated by the Hang Seng falling below a strong technical support level of 24,000, according to analysts.

In early European trades, the pan-region Euro Stoxx 50 futures STXEc1 were down 0.63% at 4,080, German DAX futures FDXc1 were down 0.43% at 15,209, FTSE futures FFIc1 were down 0.43% at 7,084.5. U.S. stock futures, the S&P 500 e-minis ESc1 , were down 0.53% at 4,634.3.

"Investors are still trying to digest what the new variant could mean in terms of of any policy response ... will there be new restrictions, lockdowns and any impact for monetary policy," said Alex Wolf, JP Morgan Private Bank's head of investment strategy for Asia.

Activity in China's services sector grew at a slightly slower pace in November, official data showed on Tuesday, as the sector took a hit from fresh lockdown measures as authorities raced to contain the latest outbreak.

The official non-manufacturing Purchasing Managers' Index (PMI) fell to 52.3 in November from 52.4 in October, data from the National Bureau of Statistics (NBS) showed.

Some investors are still cautious about the impact Omicron could have in disrupting trade, travel and economic activity.

"There are so many unknowns about Omicron and the market has been jumping at shadows," said James Rosenberg, a Sydney-based financial advisor at EL&C Baillieu said.

"After such a strong run and with elevated valuations the market will always be susceptible to the odd shakeout on news that could bring risk."

Tuesday's volatility came after the Dow Jones Industrial Average .DJI on Monday rose 236.6 points, or 0.68%, to 35,135.94, the S&P 500 .SPX gained 60.65 points, or 1.32%, to 4,655.27 and the Nasdaq Composite .IXIC added 291.18 points, or 1.88%, to 15,782.83.

In Asian trading, the yield on benchmark 10-year Treasury notes US10YT=RR was at 1.4987% compared with its U.S. close of 1.529% on Monday.

The two-year yield US2YT=RR , which rises with traders' expectations of higher Fed fund rates, touched 0.5039% compared with a U.S. close of 0.51%.

Gold XAU= ticked higher in Asian trade to be $1,793.46 per ounce after weakening in the U.S. session on the back of the stronger equities markets.

U.S. crude CLc1 dipped 1.93% to $68.6 a barrel. Brent crude LCOc1 fell to $72.04 per barrel.



World FX rates YTD Link
Global asset performance Link
Asian stock markets Link



Reporting by Scott Murdoch; Editing by Lincoln Feast.


Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Usamos cookies para lhe dar a melhor experiência no nosso website. Ler mais ou alterar as configurações de cookies.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.